Literature DB >> 2445410

Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome.

A Antonelli1, P Del Guerra, A Fierabracci, E Gori, L Baschieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2445410      PMCID： PMC1248008          DOI： 10.1136/bmj.295.6604.961

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  The carcinoid syndrome.

Authors:  J A Oates
Journal:  N Engl J Med       Date:  1986-09-11       Impact factor: 91.245

2.  Calcitonin receptors in the central nervous system of the rat.

Authors:  A J Rizzo; D Goltzman
Journal:  Endocrinology       Date:  1981-05       Impact factor: 4.736

3.  Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration.

Authors:  E del Pozo; M Neufeld; K Schlüter; F Tortosa; P Clarenbach; E Bieder; L Wendel; E Nüesch; P Marbach; H Cramer
Journal:  Acta Endocrinol (Copenh)       Date:  1986-04
  3 in total
  3 in total

1.  [2 year interferon therapy of metastatic carcinoid tumor].

Authors:  W von Scheidt; M Böhm; I Huber; R Habersetzer; K Jacob; A Markl; G Autenrieth
Journal:  Klin Wochenschr       Date:  1990-02-15

2.  Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis.

Authors:  E Roti; R Minelli; E Gardini; M Salvi; L Bianconi; L Balducci; A Manfredi; L E Braverman
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

3.  Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome.

Authors:  A Antonelli; C Gambuzza; F Bertoni; L Baschieri
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.